Cost-effectiveness of extended-release niacin/laropiprant added to a stable simvastatin dose in secondary prevention patients not at cholesterol goal in Germany
Year of publication: |
2012
|
---|---|
Authors: | Michailov, Galin ; Davies, Glenn ; Krobot, Karl |
Published in: |
The European Journal of Health Economics. - Springer. - Vol. 13.2012, 3, p. 365-374
|
Publisher: |
Springer |
Subject: | Cost-effectiveness | Dyslipidaemia | Extended-release niacin | Hypercholesterolaemia | Laropiprant | Simvastatin |
-
Tarraga-Lopez, Pedro J., (2005)
-
Simvastatin After Orthotopic Heart Transplantation: Costs and Consequences
Krobot, Karl J., (1999)
-
Koren, Michael J., (1998)
- More ...
-
The UK Economy: Analysis and Prospects.
Walker, John, (1985)
-
Fiscal policy stimulations : a comparative model exercise
Davies, Glenn, (1986)
-
Fiscal policy simulations : a comparison of UK models
Davies, Glenn, (1988)
- More ...